Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Respiratory Medicine|April 10, 2019
The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung diseaseRebeccah M Brusca, Iago Pinal-Fernandez, Kevin Psoter, et al.
Clinical Rheumatology|April 9, 2017
"Hiker's feet": a novel cutaneous finding in the inflammatory myopathiesJacob T Cox, David M Gullotti, Christopher A Mecoli, et al.
Rheumatology (Oxford, England)|January 19, 2017
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathyEleni Tiniakou, Iago Pinal-Fernandez, Thomas E Lloyd, et al.
Clinical and Experimental Rheumatology|January 9, 2026
Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre studyCody R Calhoun, Caoilfhionn M Connolly, Jemima Albayda, et al.
Arthritis Care & Research|April 21, 2015
Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune DiseasesThomas E Lloyd, Lisa Christopher-Stine, Iago Pinal-Fernandez, et al.
The Journal of Rheumatology|August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis SymptomsLisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.
Rheumatology (Oxford, England)|May 25, 2024
Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies-a potential lifesaving interventionBoyang Zheng, Ellen Eline, Lillian Xu, et al.
Rheumatology (Oxford, England)|September 19, 2025
N-formyl methionine peptide-driven neutrophil activation in idiopathic inflammatory myopathiesJorge A Gonzalez-Chapa, Begum Horuluoglu, Antonella Notarnicola, et al.
Chest|February 20, 2009
Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literatureMeena Kalluri, Steven A Sahn, Chester V Oddis, et al.
Pageof 18